Assyro AI

Orange Book product · Generic (ANDA)

PIPERACILLIN

PIPERACILLIN SODIUM

Generic (ANDA)ANDA 065114RX ISTITUTO BIO ITA SPA

At a glance

Nov 14, 2003

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 14, 2003

    22 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

PIPERACILLIN SODIUM

Strength

EQ 3GM BASE/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

ANDA 065114

Product number

002

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of PIPERACILLIN SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.